1. Catalog
  2. AACE Annual Meeting 2026 On-Demand
AACE Annual Meeting 2026 On-Demand
Didn't make it to the AACE 2026 Annual Meeting? You can still access all the invaluable insights and groundbreaking discoveries with our on-demand session recordings. Gain newfound knowledge to improve patient outcomes, assess the potential applications of emerging scientific advances, and earn up to 47.25 CME/CE/MOC credits for eligible recorded sessions. Don't miss this opportunity to elevate your practice and professional growth—register now and experience the transformative content from AACE 2026 at your own pace.
Availability
On-Demand
7 Courses
Expires on Apr 30, 2027
Cost
Member: $839.00
Non-Member: $1,049.00
Credit Offered
47.25 CME Credits
47.25 Nursing Credits
47.25 ABIM-MOC Points
6.25 ABOM Credits
  • Course Description
  • Learning Objectives
  • Target Audience
  • Accreditation and Designation Statements
  • Disclosures and Conflicts of Interest
  • Recommended

Didn't make it to the AACE Annual Meeting 2026? You can still access all the invaluable insights and groundbreaking discoveries with our on-demand session recordings. Gain newfound knowledge to improve patient outcomes, assess the potential applications of emerging scientific advances, and earn up to 47.25 CME/CE/MOC credits for eligible recorded sessions. Don't miss this opportunity to elevate your practice and professional growth—register now and experience the transformative content from AACE 2026 at your own pace.

Important Note: The QR codes and Q&A functionality are no longer available as these sessions were delivered LIVE at AACE 2026. 

Upon successful completion of the program, participants should be better able to:  
  • Discuss the latest scientific and clinical discoveries in the field of endocrinology, diabetes, and metabolism. 
  • Apply newfound knowledge to diagnosis and management for improved patient outcomes. 
  • Assess the potential applications of emerging scientific advances that affect the practice of endocrinology. 
  • Empower participants to educate their patients regarding clinical treatment options.
This program is intended for medical professionals from the field of clinical endocrinology at all stages in their career including clinical endocrinologists, primary care physicians, physician assistants, nurse practitioners, nurses, pharmacists, registered dietitians, medical students, residents, and fellows in training.
Physicians and Physician Assistants
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 47.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 47.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit. Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.

Nurses
American Association of Clinical Endocrinology is approved by the California Board of Registered Nursing, Provider Number 17762, for 47.25 contact hours.

ABOM
Applicants for certification through the American Board of Obesity Medicine (ABOM) may claim up to 6.25 GROUP TWO CME credits toward the ABOM application requirement for completion of AACE’s Nutrition and Obesity sessions.
The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Planning Committee Disclosures

Low Wang, Cecilia

Ineligible Company

(1) Dexcom, Virta Health (2) Dexcom, Virta Health

Relevant Financial Relationship

(1) Research Funding; (2) Stock

Isaacs, Diana

Ineligible Company

(1) Abbott, Dexcom, Medtronic, Insulet, Lilly, Novo Nordisk, Cequr, Sanofi (2) Lilly, Sanofi, Medtronic, Lifescan, Sequel 

Relevant Financial Relationship

(1) Speakers Bureau; (2) Consultant


Kotwal, Anupam

Ineligible Company

(1) Immunovant (2) Ascendis, Veracyte (3) Interpace Diagnostics, Immunovant, Veracyte

Relevant Financial Relationship

(1) Research Funding (2) Speakers Bureau (3) Consultant

Schulman-Rosenbaum, Rifka

Ineligible Company

(1) Sanofi

Relevant Financial Relationship

(1) Consultant  


All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

Faculty Disclosures

 

Android App Download IOS App Download Powered By